SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : PFE (Pfizer) How high will it go?
PFE 25.07-0.1%Nov 17 3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Anthony Wong who wrote (3743)6/27/1998 4:22:00 PM
From: LR  Read Replies (2) of 9523
 
Anthony, a prediction for EPS?

From that article:
Since Viagra hit the market in April, Pfizer said two
million men have tried the drug. Scott-Levin, a
health-care market research company, said $135.5
million of Viagra was sold by the end of May.


This quarter EPS est. is $0.44(low is $0.41, high is $0.55). Last year was $0.35 for June.

Last qtr = $0.53 with Net Income $692M. Profit Margin = 20.7%
Assume Viagra Revenues = 2 months(May and June) X $135.5M X 0.8(CF is Conservative Factor, i.e. minus advertising, April viagra sales and Rx declines, June viagra same sales volume, etc.)= $216M.

With (Profit Margin)20.7% X $216M = $44.7M additional Net Income. Assume Net Income of same as last qtr($692M) + $44.7M = $736M.
EPS = $736M/1.31B > $0.56 with greater upside(see CF and Profit Margin for Viagra same as company).

Comments and input welcome.
Thanks,
LR
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext